Pharmacogenomics · 2018 · 20 citations · 36 references
Veterinary MedicineGeneticsMolecular GeneticsHuman GeneticsPharmacogeneticsPopulation GeneticsComparative PharmacogeneticsGenotyping PlatformsHigh-throughput GenotypingPharmacogenetic TestingPopulation PharmacogeneticsCyp2d6 GenotypeCyp2d6 GenotypingCyp2d6 PharmacogeneticsCytochrome P450 Genetic PolymorphismCytochrome P450 GenotypingEnzyme Activity
The highly polymorphic CYP2D6 gene locus leads to a wide range of enzyme activity. Since there are limited data for Thai, the major aim was to investigate CYP2D6 genetic variation in a large Thai population (n = 920). CYP2D6 genotyping was performed using four different platforms. Genotype call rates of the Luminex xTAG® and AmpliChip CYP450 test were 96.5% and 87.4%, respectively. Based on Luminex xTAG® data, the most common alleles and genotypes were *1 0 (49.6%), *1 (24.6%), *2 (10.8%), *5 (6.7%), *41 (6.5%) and *1/*10 (23.9%), *10/*10 (21.5%), *2/*10 (9.4%), *5/*10 (6.9%), *10/*41 (5.7%), respectively. Challenges and limitations of the platforms evaluated are discussed. These data add to our knowledge regarding interethnic variability in CYP2D6 activity and contribute to improving drug therapy in the Thai.
36
Kristine R. Crews, Andrea Gaedigk, Henry M. Dunnenberger et al. · Clinical Pharmacology & Therapeutics · 2014 · 678 citations · Full text
Prediction of CYP2D6 phenotype from genotype across world populations
Andrea Gaedigk, Katrin Sangkuhl, Michelle Whirl‐Carrillo et al. · Genetics in Medicine · 2016 · 516 citations · Full text
Medicine, Biochemistry, Pharmacology +17
Andrea Gaedigk, Magnus Ingelman‐Sundberg, Neil Miller et al. · Clinical Pharmacology & Therapeutics · 2017 · 420 citations · Full text